S&P 500 falls as traders turn sour on tech
Investing.com - Mizuho has lowered its price target on LyondellBasell Industries (NYSE:LYB) to $52.00 from $54.00 while maintaining a Neutral rating on the stock. With LYB currently trading at $46.42, the new target still implies about 12% upside potential. According to InvestingPro data, the stock is considered undervalued based on its Fair Value assessment.
The price target reduction represents a $2.00 decrease from the firm’s previous valuation of the chemical company’s shares.
Mizuho’s adjustment comes ahead of the November 6 earnings report from Ligand, though the connection between this report and LyondellBasell’s price target change was not specified in the analyst’s comments.
The firm’s analyst notes mentioned several pharmaceutical products including Filspari and Ohtuvayre as key quarterly drivers, though these appear unrelated to LyondellBasell’s chemical manufacturing business.
LyondellBasell Industries is one of the world’s largest plastics, chemicals, and refining companies, producing materials used in packaging, electronics, automotive components, and construction materials.
In other recent news, LyondellBasell Industries announced its third-quarter 2025 financial results, revealing a strong performance with earnings per share (EPS) of $1.01 and an EBITDA of $835 million. The company emphasized improvements in cash flow and operational efficiencies during this period. Despite the solid financial report, the market’s response was neutral, with no change in the stock price. These developments highlight LyondellBasell’s ongoing efforts to enhance its financial health and operational capabilities. No additional news regarding mergers or acquisitions was reported for the company. Analysts’ assessments or upgrades were not mentioned in the recent news. LyondellBasell continues to focus on maintaining robust financial performance and operational improvements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.